OMNICARE PHARMACY LIMITED
Get an alert when OMNICARE PHARMACY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-06-30 (in 1mo)
Last filed for 2024-12-31
Confirmation statement due
2027-03-20 (in 10mo)
Last made up 2026-03-06
Watchouts
None on the register
Cash
£4M
+29.6% vs 2023
Net assets
£2M
+29.1% vs 2023
Employees
206
-0.5% vs 2023
Profit before tax
£2M
+47.1% vs 2023
Net assets
7-year trend · vs Industrials median
Accounts
7-year trend · latest reflected 2024-12-31
| Metric | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | £25,953,043 | £26,418,918 | |
| Operating profit | — | — | — | — | — | £1,703,072 | £2,150,176 | |
| Profit before tax | — | — | — | — | — | £1,124,410 | £1,653,928 | |
| Net profit | — | — | — | — | — | £624,895 | £1,088,138 | |
| Cash | — | — | — | — | — | £3,151,197 | £4,083,746 | |
| Total assets less current liabilities | — | — | — | — | — | £1,937,706 | £9,017,349 | |
| Net assets | — | — | — | — | — | £1,724,748 | £2,226,886 | |
| Equity | £2,176,953 | — | — | — | — | £1,724,748 | £2,226,886 | |
| Average employees | — | — | — | — | — | 207 | 206 | |
| Wages | — | — | — | — | — | £3,728,564 | £3,841,619 | |
| Directors' remuneration | — | — | — | — | — | £42,202 | £47,890 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+1.8%
£25,953,043 £26,418,918
-
Cash
+29.6%
£3,151,197 £4,083,746
-
Net assets
+29.1%
£1,724,748 £2,226,886
-
Employees
-0.5%
207 206
-
Operating profit
+26.3%
£1,703,072 £2,150,176
-
Profit before tax
+47.1%
£1,124,410 £1,653,928
-
Wages
+3%
£3,728,564 £3,841,619
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | 6.6% | 8.1% | |
| Net margin | — | — | — | — | — | 2.4% | 4.1% | |
| Return on capital employed | — | — | — | — | — | 87.9% | 23.8% | |
| Gearing (liabilities / total assets) | — | — | — | — | — | 88.8% | 85.4% | |
| Current ratio | — | — | — | — | — | 0.63x | 1.48x | |
| Interest cover | — | — | — | — | — | 2.94x | 4.20x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- OMNICARE PHARMACY LIMITED 2003-10-31 → present
- ORCHARD INCORPORATIONS (61S) LIMITED 2003-10-08 → 2003-10-31
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors are satisfied that the company has adequate resources to continue to operate for the foreseeable future. Auditors concluded directors' use of the going concern basis of accounting is appropriate and identified no material uncertainties casting significant doubt on the company's ability to continue for at least twelve months.”
Significant events
- “Bank loans were rebanked in the year and are being repaid in line with the loan agreements and performance covenants continue to be met.”
- “In January 2024 the company refinanced the loan £7,850,000 with the Bank of Scotland. The loans are repayable over 10 years, the interest rate is variable on agreement the rate was 7.25%.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 8 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FREELAND, Christopher James | Director | 2003-11-17 | Oct 1976 | British |
| O'MALLEY, Dara John | Director | 2003-11-17 | Jun 1975 | Irish |
Show 8 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FREELAND, George Keith | Secretary | 2007-04-03 | 2025-10-01 |
| O'MALLEY, Dara John | Secretary | 2003-11-17 | 2007-04-03 |
| QUEENSFERRY SECRETARIES LIMITED | Corporate Nominee Secretary | 2003-10-08 | 2003-11-17 |
| FREELAND, George Keith | Director | 2006-07-01 | 2025-10-01 |
| HUTCHISON, Frances | Director | 2008-06-01 | 2014-03-31 |
| MCCREADY, Fiona Kent | Director | 2008-01-11 | 2008-12-31 |
| QUEENSFERRY FORMATIONS LIMITED | Corporate Nominee Director | 2003-10-08 | 2003-11-17 |
| QUEENSFERRY REGISTRATIONS LIMITED | Corporate Nominee Director | 2003-10-08 | 2003-11-17 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 94 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-19 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-12-03 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-12-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-12 | SH03 | capital | Capital return purchase own shares | |
| 2025-11-12 | SH03 | capital | Capital return purchase own shares | |
| 2025-09-04 | AA | accounts | Accounts with accounts type full | |
| 2025-05-20 | AA01 | accounts | Change account reference date company current shortened | |
| 2025-03-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-07-25 | AA | accounts | Accounts with accounts type full | |
| 2024-03-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-02-09 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-02-09 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-07-31 | AA | accounts | Accounts with accounts type full | |
| 2023-03-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-28 | AA | accounts | Accounts with accounts type full | |
| 2022-03-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-29 | AA | accounts | Accounts with accounts type full | |
| 2021-03-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-08-17 | AA | accounts | Accounts with accounts type full | |
| 2020-03-10 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 2
- Officers appointed
- 0
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.